Characteristics and Outcomes of Patients With IDH-Mutant Grade 2 and 3 Gliomas After Deferred or Adjuvant Radiotherapy
{{output}}
Background and objectives: Current treatment guidelines for patients with isocitrate dehydrogenase (IDH)-mutant (IDHm) glioma recommend radiation (XRT) and chemotherapy after surgery in most cases based on studies in which XRT wa... ...
